Nath Bio-Genes (India) Limited (BOM:537291)
India · Delayed Price · Currency is INR 145.85
-5.15 (-3.41%)
At close: Dec 4, 2025
Nath Bio-Genes (India) Revenue
Nath Bio-Genes (India) had revenue of 438.50M INR in the quarter ending September 30, 2025, with 36.21% growth. This brings the company's revenue in the last twelve months to 4.17B, up 18.67% year-over-year. In the fiscal year ending March 31, 2025, Nath Bio-Genes (India) had annual revenue of 3.65B with 9.70% growth.
Revenue (ttm)
4.17B
Revenue Growth
+18.67%
P/S Ratio
0.64
Revenue / Employee
9.24M
Employees
451
Market Cap
2.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.65B | 322.73M | 9.70% |
| Mar 31, 2024 | 3.33B | 314.02M | 10.42% |
| Mar 31, 2023 | 3.01B | 230.01M | 8.26% |
| Mar 31, 2022 | 2.78B | -291.99M | -9.49% |
| Mar 31, 2021 | 3.08B | 276.70M | 9.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |
Nath Bio-Genes (India) News
- 12 days ago - Nath Bio-Genes (India) Ltd (BOM:537291) Q2 2026 Earnings Call Highlights: Strong Revenue and ... - GuruFocus